{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:39Z","timestamp":1793336319885,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T00:00:00Z","timestamp":1628380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1053\/j.gastro.2021.07.046","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:59:05Z","timestamp":1628546345000},"page":"1764-1775.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process"],"prefix":"10.1053","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5203-0453","authenticated-orcid":false,"given":"Cyriel Y.","family":"Ponsioen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Deneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Aabakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martti","family":"F\u00e4rkkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"H\u00fcbscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2021.07.046_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib5","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib6","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.07.046_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.07.046_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"issue":"7","key":"10.1053\/j.gastro.2021.07.046_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234624","article-title":"The Primary Sclerosing Cholangitis (PSC) Wellbeing study: understanding psychological distress in those living with PSC and those who support them","volume":"15","author":"Ranieri","year":"2020","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2021.07.046_bib12","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.29882","article-title":"Design and endpoints for clinical trials in primary sclerosing cholangitis","volume":"68","author":"Ponsioen","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.29664","article-title":"Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: the PSC PRO","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib14","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/liv.14644","article-title":"The Simple Cholestatic Complaints Score is a valid and quick patient-reported outcome measure in primary sclerosing cholangitis","volume":"40","author":"Munster","year":"2020","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2021.07.046_bib15","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s10620-015-4013-1","article-title":"Factors that influence health-related quality of life in patients with primary sclerosing cholangitis","volume":"61","author":"Cheung","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.07.046_bib16","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.27715","article-title":"Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation","volume":"61","author":"Poupon","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: a systematic review","volume":"18","author":"Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1053\/j.gastro.2021.07.046_bib19","doi-asserted-by":"crossref","first-page":"102618","DOI":"10.1016\/j.autrev.2020.102618","article-title":"2020 International consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"Moiseev","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.gastro.2021.07.046_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value\u00a0of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.07.046_bib22","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1007\/s00261-020-02572-w","article-title":"Magnetic resonance imaging features of small-duct primary sclerosing cholangitis","volume":"45","author":"Kozaka","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"10.1053\/j.gastro.2021.07.046_bib23","doi-asserted-by":"crossref","first-page":"109101","DOI":"10.1016\/j.ejrad.2020.109101","article-title":"Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC)","volume":"129","author":"Ringe","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.gastro.2021.07.046_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gie.2009.10.041","article-title":"Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment","volume":"71","author":"Gotthardt","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2021.07.046_bib26","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/j.1572-0241.1999.01364.x","article-title":"Four years experience with short term stenting in primary sclerosing cholangitis","volume":"94","author":"Ponsioen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2018.05.034","article-title":"No superiority of stents vs balloon dilatation for dominant strictures in patients with primary sclerosing cholangitis","volume":"155","author":"Ponsioen","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib28","article-title":"Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group","author":"Venkatesh","year":"2021","journal-title":"Eur Radiol [Published online ahead of print"},{"key":"10.1053\/j.gastro.2021.07.046_bib29","series-title":"MacSweens liver pathology","first-page":"515","article-title":"Bile duct diseases","author":"Zen","year":"2017"},{"key":"10.1053\/j.gastro.2021.07.046_bib30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"key":"10.1053\/j.gastro.2021.07.046_bib32","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2015.06.008","article-title":"Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis","volume":"63","author":"de Vries","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12072-011-9260-4","article-title":"Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature","volume":"5","author":"Singal","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2021.07.046_bib35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib36","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/hep.30276","article-title":"Recommendations on the use of magnetic resonance imaging for collaborative multicenter studies in primary sclerosing cholangitis","volume":"69","author":"Ringe","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore","volume":"17","author":"Ang","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","article-title":"Geoepidemiology of primary sclerosing cholangitis: a critical review","volume":"46","author":"Tanaka","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1053\/j.gastro.2021.07.046_bib39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"Jorgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.07.046_bib40","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.07.046_bib41","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/MEG.0000000000000660","article-title":"Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands","volume":"28","author":"de Groof","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib43","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/liv.14645","article-title":"Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis","volume":"40","author":"Culver","year":"2020","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2021.07.046_bib44","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib46","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A\u00a0preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib47","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hep.30237","article-title":"Simtuzumab for primary sclerosing cholangitis: phase 2 study results with insights on the natural history of the disease","volume":"69","author":"Muir","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.28963","article-title":"Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: an international cohort study","volume":"65","author":"de Vries","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jcp.48.10.933","article-title":"Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis","volume":"48","author":"Olsson","year":"1995","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1053\/j.gastro.2021.07.046_bib50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib51","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib52","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/0016-5085(92)91449-E","article-title":"Primary sclerosing cholangitis: refinement and validation of survival models","volume":"103","author":"Dickson","year":"1992","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1053\/j.gastro.2021.07.046_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164224","article-title":"Validation of transient elastography and comparison with spleen length measurement for staging of fibrosis and clinical prognosis in primary sclerosing cholangitis","volume":"11","author":"Ehlken","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2021.07.046_bib55","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jgh.13263","article-title":"Performance of magnetic resonance elastography in primary sclerosing cholangitis","volume":"31","author":"Eaton","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib56","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21151","article-title":"Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC","volume":"43","author":"Corpechot","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib57","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib58","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1016\/S0168-8278(17)31056-5","article-title":"Liver stiffness measurement by transient elastography for the prediction of fibrosis in patients with primary sclerosing cholangitis in a randomized trial of simtuzumab","volume":"66","author":"Bowlus","year":"2017","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib59","unstructured":"Bowlus CL, Patel K, Guha IN. Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab. Hepatology 2015;62:519a."},{"key":"10.1053\/j.gastro.2021.07.046_bib60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.27825","article-title":"Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis","volume":"62","author":"Vesterhus","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib61","first-page":"56","article-title":"Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study","volume":"114","author":"de Vries","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"10.1053\/j.gastro.2021.07.046_bib62","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1016\/S0168-8278(17)31056-5","article-title":"Prospective validation of the Enhanced Liver Fibrosis test for the prediction of disease progression in a randomized trial of patients with primary sclerosing cholangitis","volume":"66","author":"Bowlus","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"4 Pt B","key":"10.1053\/j.gastro.2021.07.046_bib63","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.bbadis.2017.08.015","article-title":"Endpoints in the design of clinical trials for primary sclerosing cholangitis","volume":"1864","author":"Ponsioen","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1053\/j.gastro.2021.07.046_bib64","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.30085","article-title":"Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) predicts outcomes in PSC: a derivation & validation study using machine learning","volume":"71","author":"Eaton","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cld.2015.08.014","article-title":"Cancer risk and surveillance in primary sclerosing cholangitis","volume":"20","author":"Folseraas","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2021.07.046_bib68","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000128169","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience","volume":"25","author":"Morris-Stiff","year":"2008","journal-title":"Dig Surg"},{"key":"10.1053\/j.gastro.2021.07.046_bib69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1478-3231.2011.02575.x","article-title":"Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study","volume":"32","author":"Fevery","year":"2011","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2021.07.046_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","article-title":"Cholangiocarcinoma: current knowledge and new developments","volume":"11","author":"Blechacz","year":"2017","journal-title":"Gut Liver"},{"key":"10.1053\/j.gastro.2021.07.046_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.gastro.2021.07.046_bib72","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2021.07.046_bib73","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/apt.13817","article-title":"Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"44","author":"Njei","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.07.046_bib74","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOG.0b013e3282f5727a","article-title":"Gallbladder polyps in primary sclerosing cholangitis: not so benign","volume":"24","author":"Karlsen","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib75","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2021.07.046_bib76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"28","author":"Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib77","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"issue":"134","key":"10.1053\/j.gastro.2021.07.046_bib78","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/134.6.876","article-title":"Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis","author":"Harpaz","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.gastro.2021.07.046_bib79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib80","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.3748\/wjg.v20.i27.8783","article-title":"Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/00365521.2012.685754","article-title":"Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study","volume":"47","author":"J\u00f8rgensen","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib82","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib83","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MPG.0000000000001368","article-title":"The natural history of primary sclerosing cholangitis in children","volume":"63","author":"Valentino","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2021.07.046_bib84","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bj\u00f6rnsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib85","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib86","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3109\/00365529709011222","article-title":"Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study","volume":"32","author":"Kornfeld","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib87","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with PSC","volume":"33","author":"van Buuren","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib88","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib89","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/jlts.2002.33952","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation","volume":"8","author":"Graziadei","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2021.07.046_bib90","series-title":"MacSweens liver pathology","first-page":"880","article-title":"Bile duct diseases","author":"Clouston","year":"2017"},{"key":"10.1053\/j.gastro.2021.07.046_bib91","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib92","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.07.046_bib93","doi-asserted-by":"crossref","unstructured":"Miard C, Desfourneaux V, Dewitte M. Usefulness of systematic liver biopsy during a surgery for inflammatory bowel disease for the diagnosis of primary sclerosing cholangitis. J Crohn\u2019s Colitis 2018;12(Suppl 1):S209.","DOI":"10.1093\/ecco-jcc\/jjx180.344"},{"key":"10.1053\/j.gastro.2021.07.046_bib94","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.dld.2018.06.024","article-title":"Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease","volume":"50","author":"Belle","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2021.07.046_bib95","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/liv.14645","article-title":"Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis","volume":"40","author":"Culver","year":"2020","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2021.07.046_bib96","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3748\/wjg.v26.i23.3126","article-title":"Review of primary sclerosing cholangitis with increased IgG4 levels","volume":"26","author":"Manganis","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib97","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib98","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00535-009-0130-y","article-title":"Primary sclerosing cholangitis with elevated serum IgG4 levels and\/or infiltration of abundant IgG4-positive plasma cells","volume":"45","author":"Koyabu","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib99","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulinG4: clinical characteristics and response to therapy","volume":"18","author":"Bj\u00f6rnsson","year":"2011","journal-title":"Am J Ther"},{"key":"10.1053\/j.gastro.2021.07.046_bib100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib101","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2018.05.034","article-title":"No superiority of stents vs balloon dilatation for dominant strictures in patients with primary sclerosing cholangitis","volume":"155","author":"Ponsioen","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib102","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib103","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.07.046_bib104","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.gastro.2021.07.046_bib105","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ibd.21569","article-title":"Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea","volume":"17","author":"Ye","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.07.046_bib106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"issue":"9904","key":"10.1053\/j.gastro.2021.07.046_bib107","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.07.046_bib108","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02258391","article-title":"Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study","volume":"40","author":"Lundqvist","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2021.07.046_bib109","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.3748\/wjg.14.3497","article-title":"Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"14","author":"Sokol","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib110","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1111\/j.1572-0241.1999.01543.x","article-title":"Time course of histological progression in PSC","volume":"94","author":"Angulo","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib111","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A\u00a0preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.07.046_bib112","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib113","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCG.0b013e3181662426","article-title":"A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis","volume":"42","author":"Hommes","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib114","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.07.046_bib116","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib117","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2007.12.023","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective","volume":"48","author":"Cullen","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib118","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hep.30237","article-title":"Simtuzumab for primary sclerosing cholangitis: Phase 2 study results with insights on the natural history of the disease","volume":"69","author":"Muir","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2021.07.046_bib119","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/TP.0b013e31821694b3","article-title":"Current trends in living donor liver transplantation for primary sclerosing cholangitis","volume":"91","author":"Goldberg","year":"2011","journal-title":"Transplantation"},{"key":"10.1053\/j.gastro.2021.07.046_bib120","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/lt.22396","article-title":"Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era","volume":"17","author":"Goldberg","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2021.07.046_bib121","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00423-014-1214-6","article-title":"Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the model for end-stage liver disease era","volume":"399","author":"Klose","year":"2014","journal-title":"Langenbecks Arch Surg"},{"key":"10.1053\/j.gastro.2021.07.046_bib122","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s11605-020-04721-4","article-title":"Liver transplantation for peri-hilar cholangiocarcinoma","volume":"24","author":"Tan","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1053\/j.gastro.2021.07.046_bib123","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/00365521.2015.1028996","article-title":"Primary sclerosing cholangitis \u2013 the Norwegian experience","volume":"50","author":"Schrumpf","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.07.046_bib124","unstructured":"Charcot JM. Lecons sur les maladies du fore des voies biliares et des veins faites \u00e0 la Facult\u00e9 de M\u00e9dicine de Paris. Paris: Bournesville & Sevestre, 1877."},{"key":"10.1053\/j.gastro.2021.07.046_bib125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrgastro.2009.126","article-title":"Diagnosis and management of acute cholangitis","volume":"6","author":"Lee","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.07.046_bib126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00534-006-1156-7","article-title":"Diagnostic criteria and severity assessment of acute cholangitis: Tokyo guidelines","volume":"14","author":"Wada","year":"2007","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1053\/j.gastro.2021.07.046_bib127","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00534-012-0561-3","article-title":"TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)","volume":"20","author":"Kiriyama","year":"2013","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1053\/j.gastro.2021.07.046_bib128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jhbp.512","article-title":"Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)","volume":"25","author":"Kiriyama","year":"2018","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1053\/j.gastro.2021.07.046_bib129","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cgh.2015.07.014","article-title":"Inflammation but not biliary obstruction is associated with carbohydrate antigen 19-9 levels in patients with primary sclerosing cholangitis","volume":"13","author":"Wannhoff","year":"2015","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521033461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521033461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T22:46:32Z","timestamp":1709765192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521033461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0016508521033461"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2021.07.046","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2021.07.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}